Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Annals of Allergy, Asthma & Immunology - Volume 107, Issue 6, December 2011, Pages 529-537.e2

William R. MD, H. Henry MD, PhD, Robyn J. MD, Paul C. FCP(SA), MD (Cape Town), Henriette MD, PhD, DSc, Dumitru MD, PhD, Marc MD, Hongbin MS, Timothy DO, Bradley J. MD, Avner MD,